Patrick Grenier - Publications

Affiliations: 
Queen's University, Kingston, ON, Canada 
Area:
Chronic pain, tolerance, GPCRs

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Grenier P, Sunavsky A, Olmstead MC. Morphine Induces Upregulation of Neuronally Expressed CB2 Receptors in the Spinal Dorsal Horn of Rats. Cannabis and Cannabinoid Research. 6: 137-147. PMID 33912678 DOI: 10.1089/can.2020.0004  1
2020 Cahill CM, Holdridge SV, Liu SS, Xue L, Magnussen C, Ong E, Grenier P, Sutherland A, Olmstead MC. Delta opioid receptor activation modulates affective pain and modality-specific pain hypersensitivity associated with chronic neuropathic pain. Journal of Neuroscience Research. PMID 32623788 DOI: 10.1002/Jnr.24680  1
2019 Grenier P, Mailhiot MC, Cahill CM, Olmstead MC. Blockade of dopamine D1 receptors in male rats disrupts morphine reward in pain naïve but not in chronic pain states. Journal of Neuroscience Research. PMID 31721270 DOI: 10.1002/Jnr.24553  1
2018 Grenier P, Wiercigroch D, Olmstead MC, Cahill CM. Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists. Behavioural Pharmacology. PMID 29481424 DOI: 10.1097/Fbp.0000000000000377  1
2014 Milne B, Jhamandas K, Sutak M, Grenier P, Cahill CM. Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the α2A-adrenoceptor selective antagonist BRL44408. European Journal of Pharmacology. 743: 89-97. PMID 25242119 DOI: 10.1016/J.Ejphar.2014.08.040  1
2013 Cahill CM, Xue L, Grenier P, Magnussen C, Lecour S, Olmstead MC. Changes in morphine reward in a model of neuropathic pain. Behavioural Pharmacology. 24: 207-13. PMID 23591124 DOI: 10.1097/Fbp.0B013E3283618Ac8  1
2013 Milne B, Jhamandas K, Sutak M, Grenier P, Cahill CM. Stereo-selective inhibition of spinal morphine tolerance and hyperalgesia by an ultra-low dose of the alpha-2-adrenoceptor antagonist efaroxan. European Journal of Pharmacology. 702: 227-34. PMID 23376415 DOI: 10.1016/J.Ejphar.2013.01.022  1
Show low-probability matches.